Home›Companies›Biotech & Pharma›Native Cardio

Native Cardio, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 5, 2025·Suggest an edit

About Native Cardio

Native Cardio is a private company based in Naples, Florida. It has reported $3,115,241 raised in three offerings on Form D since February 2019. Its chief executive is Joseph Pergolizzi.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 25, 2025Mar 5, 2025$150,000of $1.0M target1$150KSAFE (Simple Agreement for Future Equity)Rule 506(b)Form D ↗
May 6, 2021May 11, 2021amended Mar 1, 2023$465,000of $5.0M target7$66,429Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Feb 8, 2019Feb 12, 2019amended Jan 26, 2021$2,500,241of $6.0M target5$500KEquityRule 506(b)Form D/A ↗2 earlier filings
Total, three offerings$3,115,241

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Native Cardio's Form D filed Mar 5, 2025.

JP
Joseph Pergolizzi
President & CEO, director
Also a director at Neumentum.
YK
Young Kim
Director

Earlier filings also listed Gary Dixon (executive officer, last listed Jan 2021).

Sources

  1. SECNative Cardio, Inc. Form D, filed May 11, 2021
  2. SECNative Cardio, Inc. Form D/A, filed Jan 29, 2020
  3. SECNative Cardio, Inc. Form D, filed Feb 12, 2019
  4. SECNative Cardio, Inc. filing history